期刊文献+

非诺贝特和TNF-α对3T3-L1脂肪细胞内脂素表达的影响 被引量:2

Effects of fenofibrate and TNF-α on visfatin mRNA expression in 3T3-L1 adipocytes
下载PDF
导出
摘要 目的研究非诺贝特和肿瘤坏死因子α(TNF-α)对3T3-L1脂肪细胞内脂素(Visfatin)表达的影响。方法分化成熟的3T3-L1脂肪细胞,用不同终浓度非诺贝特(0、50、100、200μmol/L)刺激48 h;用100μmol/L非诺贝特刺激不同时间(0、12、24、48 h);用10 ng/ml TNF-α和10 ng/ml TNF-α加100μmol/L非诺贝特联合刺激48h。使用半定量RT-PCR法检测3T3-L1脂肪细胞Visfatin mRNA的表达。结果Visfatin mRNA表达随非诺贝特浓度增加、作用时间延长而增加;TNF-α作用48 h后Visfatin mRNA表达量减少(P<0.05),联用非诺贝特组高于TNF-α组(P<0.01)。结论非诺贝特能促进3T3-L1脂肪细胞Visfatin表达,这可能是其改善胰岛素抵抗的机制之一。 Objective To evaluate the effects of fenofibrate and TNF-α on visfatin mRNA expression in 3T3-L1 adipocytes. Methods The differentiated 3T3-L1 adipocytes were stimulated with fenofibrate at different concentrations for 48 hours or stimulated with 100 umol/L fenofibrate for different times ; The same cells were stimulated with 10 ng/ml TNF-α, mixture of 10 ng/ml TNF-α and 100 umol/L fenofibrate. The expression of visfatin mRNA was detected by RT-PCR. Resuits In 3T3-L1 adipocytes, with the increased concentrations of fenofibrate or the stimulated time extended, visfatin mRNA expression was also increased. Compared with control group, treatment with 10 ng/ml TNF-α had significantly decreased the expression of visfatin mRNA. Meanwhile, the expression of visfatin mRNA was increased significantly treatment with mixture of 10 ng/ml TNF-α and 100umol/L fenofibrate compared with 10 ng/ml TNF-α ( P 〈 0.01 ). Conclusion Fenofibrate increased the visfatin mRNA expression in differentiated 3T3-L1 adipecytes in a time-and-dose-dependent manner, which may one of the mechanisms underlying the action of fenofibrate on improving insulin resistance.
出处 《山东医药》 CAS 北大核心 2008年第19期28-30,共3页 Shandong Medical Journal
基金 安徽省教育厅自然科学资助项目(2006KJ319B)
关键词 内脂素 313-L1脂肪细胞 非诺贝特 肿瘤坏死因子 visfatin 3T3-L1 adiocytes fenofibrate tumor necrsis factor
  • 相关文献

参考文献7

  • 1Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin [ J ]. Science, 2005,307 (5708): 426-430.
  • 2Choi KC, Ryu OH, Lee KW, et al. Effect of PPAR-alpha and gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats [J]. J Biochem Biophys Res Commun, 2005,336(3) :747-753.
  • 3Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity [J]. Nat Rev Immunol, 2006,6 (10) :772-783.
  • 4Kralisch S, Klein J, Lossner U, et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes [ J ]. Am J Physiol Endocrinol Metab, 2005,289(4) :E586-590.
  • 5MacLaren R, Cui W, Cianflone K. Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes [ J]. Diabetes Obes Metab, 2007,9(4) :490-497.
  • 6Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance [ J ]. Exp Clin Endocrinol Diabetes, 1999,107 (2) : 119 -125.
  • 7Koh EH, Kim MS, Park JY, et al. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation [ J ]. Diabetes, 2003,52 (9) :2331-2337.

同被引文献23

  • 1Michael S Kostapanos,Anastazia Kei,Moses S Elisaf.Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease[J].World Journal of Hepatology,2013,5(9):470-478. 被引量:17
  • 2Wang Q, Guo T, Tao Y, et al. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome[J].Gynecol Endocrinol, 2011, 27(11):931-934.
  • 3Noureldeen AF, Qusti SY, Al-Seeni MN, et al. Maternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes[J]. Indian J Clin Biochem, 2014, 29(4):462-470.
  • 4Mazaki-Tovi S, Romero R, Kusanovic JP, et al. Maternal visfatin concentration in normal pregnancy[J]. J Perinat Med, 2009, 37(3):206-217.
  • 5Kato A, Odamaki M, Ishida J, et al. Relationship between serum Pre-B cell colony-enhancing factor/visfatin and atherosclerotic parameters in chronic hemodialysis patients[J]. Am J Nephrol, 2009, 29(1):31-35.
  • 6Vanhoutte PM. Endothelial dysfunction:the first step toward coronary arteriosclerosis[J]. Circ J, 2009, 73(4):595-601.
  • 7Palm M, Axelsson O, Wernroth L, et al. Involvement of inflammation in normal pregnancy[J]. Acta Obstet Gynecol Scand, 2013, 92(5):601-605.
  • 8Visser N, van Rijn BB, Rijkers, et al. Inflammatory changes in preeclampsia:current understanding of the maternal innate and adaptive immune response[J]. Obstet Gynecol Surv, 2007, 62(3):191-201.
  • 9Hu W, Wang Z, Wang H, et al. Serum visfatin levels in late pregnancy and pre-eclampsia[J]. Acta Obstet Gynecol Scand, 2008, 87(4):413-418.
  • 10Hauth JC, Clifton RG, Roberts JM, et al. Maternal insulin resistance and preeclampsia[J]. Am J Obstet Gynecol, 2011, 204(4):327.e1-327.e6.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部